Mirae Asset Global Investments Co., Ltd. Cardiol Therapeutics Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.48 - $1.0 $107,269 - $223,478	223,478 Added 25.67%	1,094,040 $557,000
Q3 2022 Nov 10, 2022	SELL	$1.02 - $1.41 $495,779 - $685,341	-486,058 Reduced 35.83%	870,562 $893,000
Q2 2022 Jul 26, 2022	SELL	$1.03 - $2.05 $33,182 - $66,042	-32,216 Reduced 2.32%	1,356,620 $1.78 Million
Q1 2022 Jun 02, 2022	BUY	$1.25 - $2.31 $1.74 Million - $3.21 Million	1,388,836 New	1,388,836 $2.15 Million
Q1 2022 May 10, 2022	SELL	$1.25 - $2.31 $1.31 Million - $2.41 Million	-1,045,205 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$1.83 - $4.86 $2,746 - $7,294	1,501 Added 0.14%	1,045,205 $1.93 Million
Q3 2021 Nov 15, 2021	BUY	$2.03 - $4.8 $2.12 Million - $5.01 Million	1,043,704 New	1,043,704 $4.3 Million

5.07M

5.2K

9.5K

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $94.8M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.